Current status of the cost burden of first-line systemic treatment for patients with advanced hepatocellular carcinoma in Japan, 2021-22

Although recent advances in systemic therapies for hepatocellular carcinoma (HCC) have led to prolonged patient survival, the high costs of the drugs place a heavy burden on both patients and society. The objectives of this study were to examine the treatment regimens used as first-line systemic tre...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Japanese journal of clinical oncology 2024-10, Vol.54 (10), p.1071-1077
Hauptverfasser:	Imaoka, Hiroshi, Sasaki, Keita, Machida, Ryunosuke, Nagano, Hiroaki, Satoi, Sohei, Ikeda, Masafumi, Kobayashi, Satoshi, Yamashita, Taro, Okusaka, Takuji, Ido, Akio, Hatano, Etsuro, Miwa, Haruo, Ueno, Masaki, Nakao, Kazuhiko, Shimizu, Satoshi, Kuramochi, Hidekazu, Sakamori, Ryotaro, Tsumura, Hidetaka, Okano, Naohiro, Shioji, Kazuhiko, Shirakawa, Hirofumi, Akutsu, Noriyuki, Tsuji, Kunihiro, Ishii, Hiroshi, Umemoto, Kumiko, Asagi, Akinori, Ueno, Makoto
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!